Nonredundant Roles of the Calcium-Sensing Receptor in Physiology
At first glance, the calcium-sensing receptor (CaR) belongs to the endocrinologists. It was first cloned from a bovine parathyroid gland cDNA library (6) in an effort to identify the cell surface molecule that mediates the feedback mechanism by which parathyroid cells shut off the synthesis and secretion of parathyroid hormone once the hormone has done its job: elevating the extracellular ionized calcium concentration (Ca 2ϩ o ). On the basis of the available evidence, the cloned CaR does indeed mediate this critical function. Thus the CaR null (Ϫ/Ϫ) mouse exhibits uncontrolled hyperparathyroidism and attendant hypercalcemia owing to loss of feedback control of parathyroid cells. Furthermore, humans with homozygous inactivating mutations of the CaR exhibit a closely related condition, neonatal severe hyperparathyroidism (for review, see Ref. 7) .
At second glance, the CaR also belongs to the nephrologists (47) . Unlike homozygous inactivating mutations of the CaR, heterozygous inactivating mutations have, in general, only a limited effect on parathyroid function. Thus the CaR ϩ/Ϫ mouse and humans heterozygous for inactivating CaR mutations exhibit only mild disturbances of parathyroid function. Instead, they exhibit a predominantly renal-based defect in calcium metabolism in which there is an inappropriate elevation in calcium reabsorption from the tubules. This is sufficient, when combined with mildly abnormal Ca 2ϩ -regulated parathyroid hormone (PTH) release, to elevate Ca 2ϩ o into the range commonly observed in adult primary hyperparathyroidism due to adenomatous disease (from 1.1-1.3 mM to ϳ1.3-1.5 mM) and to markedly lower the urinary calcium excretion below the normal range of ϳ2-5 mmol/day. These key clinical features of an otherwise largely benign clinical condition have led to the diagnostic name, familial hypocalciuric hypercalcemia.
Thus the CaR has key nonredundant roles in calcium homeostasis, and its most obvious roles are dependent upon its expression in the parathyroid and kidney. Interestingly, elimination of the PTH gene (35) or of the parathyroid glands themselves, via knockout of the gcm-2 gene (53) , markedly limits the severity of the CaR null phenotype, indicating that its control of the parathyroid is paramount and raising questions as to its significance in other tissues.
Thus the question might be asked: "Are all other roles of the CaR, associated with its expression in a truly diverse spectrum of tissues, essentially redundant and thus of little physiological interest?" The answer to this question appears to be, in essence, "No, there are a large number of significant, nonredundant functions of the CaR that contribute to the optimal control of function in diverse physiological systems." In the kidney, for example, local CaRs play additional roles in the regulation of water excretion by suppressing vasopressin-stimulated water reabsorption, an apparent defense against the formation of calcium-containing renal stones (for review, see Ref. 7) . CaRs also contribute to the control of Na ϩ , K ϩ , and Cl Ϫ transport in the distal nephron as revealed by the impact of severe activating mutations (56, 58) .
CaRs are also expressed widely in the gastrointestinal (GI) tract. Why are they there and what are they doing? This review focuses on the roles the CaR plays, or appears to play, in the GI tract with particular attention to its recently recognized Lamino acid-sensing function and the impact this has on the control of digestion, absorption, and satiety.
The CaR as a Family C G-Protein Coupled Receptor
When it was first cloned, the CaR was immediately identified as a G-protein coupled receptor (GPCR) from hydropathy plot analysis that indicated the presence of a repetitive hydrophobic, seven-transmembrane domain (7-TMD) motif (6, 20) (Fig. 1) . Subsequent experiments confirmed that the CaR couples to phosphatidylinositol (PI)-specific phospholipase C and induces the mobilization of intracellular Ca The CaR's atypically large NH 2 -terminal extracellular domain (residues 22-606) and its sequence homology with the metabotropic glutamate receptors led to its placement in family C or subclass 3 of the GPCR superfamily. These receptors are, in general, composed of four main protein domains: an NH 2 -terminal extracellular, nutrient-binding, Venus FlyTrap (VFT) domain of ϳ500 amino acids; a Cys-rich domain of ϳ90 amino acids that couples nutrient binding to receptor activation; a 7-TMD motif of ϳ240 amino acids; and an intracellular COOH-terminal signaling domain of ϳ230 amino acids that is required for the activation of intracellular signaling pathways (Fig. 1) . Such a large protein potentially provides binding sites for multiple biochemical species, most obviously in the VFT domain and 7-TMD regions, but also potentially in other regions.
The CaR as a Multi-Modal, Multi-Metabolic Sensor
The CaR is activated by various multivalent cations with charge density, rather than ionic radius, being a major determinant of the potency of activators as diverse as alkaline earth metals (such as Ca 2ϩ and Sr 2ϩ ), lanthanides (such as Gd 3ϩ ), polycations (such as spermidine and spermine), and cationic peptides such as poly-lysine and poly-arginine (for review, see Ref. 7) . All these cations might be presumed to bind on a common, spatially unrestricted, positive-charge-sensitive surface. Consistent with this idea, the CaR has also been shown recently to respond to changes in ionic strength and pH: low ionic strength (44) and high pH (43) sensitize the receptor to Ca 2ϩ . However, the CaR also exhibits a markedly positive cooperativity for Ca 2ϩ -induced receptor activation, pointing to the existence of multiple Ca 2ϩ binding sites, some of which may be truly selective for Ca 2ϩ ions over other multivalent cations. A recent molecular modeling analysis of the CaRs bilobed VFT domain and various mutations within this domain, for example, concluded that a Ca 2ϩ binding site exists in a discrete region of the crevice that lies between the lobes of each receptor subunit (49) .
Because the CaR protein is most closely related to receptors for amino acids, including the metabotropic glutamate receptors (mGlus) and the fish 5.24 basic amino acid receptor, and amino acid analogs, in the case of the metabotropic GABA B receptors, it seems surprising that the protein encodes a Ca 2ϩ -sensing receptor rather than a receptor for an amino acid or a biologically significant amino acid analog. In the spring of 1999, with our colleague Steve Quinn, we decided to systematically test whether the CaR might retain sensitivity to Lamino acids, either as coagonists or as allosteric activators such as the, then recently identified, phenylalkylamine type-II calcimimetics (41) . Not knowing a priori which amino acids to test or where they might bind, we initially selected L-Phe for testing because this amino acid bears some limited structural homology with the phenylalkylamines. The choice was fortunate and, we now know, quite fortuitous because L-Phe and the phenylalkylamines bind in distinct domains (40) and, in fact, exhibit positive interactions with one another as receptor activators (62) .
The CaR as an Amino Acid Receptor
For our assay system, we used HEK293 cells that stably expressed the human CaR (HEK-CaR cells). These cells exhibit a robust extracellular Ca 2ϩ -induced intracellular Ca 2ϩ mobilization response that is readily detected after loading with fura 2. The CaR responded stereoselectively to L-Phe (0.3-30 mM) with acute elevations in intracellular Ca 2ϩ concentration provided that the cells were exposed to a submaximal Ca 2ϩ o (16) (Fig. 2) . At maximally effective Ca 2ϩ concentrations (Ͼ5 mM), L-Phe had no effect. On the other hand, in the absence of Ca 2ϩ ions, or in the presence of a subthreshold Ca 2ϩ concentration (found to lie between 0.5 and 1.0 mM), L-Phe had no effect. Consistent with this behavior, we found that L-amino acids are not CaR agonists. Rather, like the phenylalkylamine type-II calcimimetics, L-Phe sensitized the CaR to Ca 2ϩ , markedly shifting the concentration response to the left. We had identified a novel allosteric enhancer or, perhaps better, given that Ca 2ϩ is present at concentrations above threshold in normal physiological fluids, an allosteric activator (31) .
There is a rather frustrating, largely old and unwieldy literature on physiological interactions between protein and calcium metabolism, plenty of evidence for links at the whole body level but very little by the way of definitive molecular or even cellular detail. So, instead, we took our next step based on observations made by GI physiologists in the 1960s and 1970s who identified a nutrient-sensing system for, in particular, aromatic amino acids, including L-Phe and L-Trp, as well as other amino acids, that appeared to provide a molecular link between protein ingestion and gastrin release (17, 50) , gastric acid secretion (27, 34, 38) , pancreatic fluid secretion (39) , and cholecystokinin (CCK) release (32) . On the basis of these results, obvious next amino acids to test were L-Trp and others, including L-His, L-Ser, and L-Ala. In the HEK-CaR cell system, L-Trp behaved in an almost identical fashion to L-Phe (Fig. 2) , and all of these amino acids were effective. We then systematically worked our way through the standard 20 genetically encoded amino acids that are all readily available for intestinal absorption from dietary protein. Many, but not all, of them were effective, and L-isomers were preferred to D-isomers, although subsequent analysis indicated that L vs. D selectivity was less marked for smaller amino acids such as Ala (15) . It seemed that half or even more than half of the 20 amino acids tested, including aromatics, polar, aliphatic, and acidic amino acids, were effective, with aromatic amino acids being the most potent. Two classes of amino acids were clearly ineffective: basic amino acids (a surprise for some scientists because, like Ca 2ϩ , they are positively charged at neutral pH) and branchedchain amino acids, such as L-Leu (16) . Systematic analysis of the functional group requirements for receptor activation using analogs of L-Ala led to two additional rules: the ␣-amino and ␣-carboxylate groups were absolutely required. Thus the receptor senses L-amino acids.
The observations described above identified several subclasses of L-amino acids as allosteric activators of the CaR and indicated that it responds to an integrated amino acid concentration, a weighted sum of all effective amino acids.
Location of the CaR's Amino Acid Binding Site
On the basis of the CaR's homology to other family C GPCRs, it might be expected that L-amino acids would bind in the cleft of the VFT domain distinct from the recognized phenylalkylamine binding site in the transmembrane domain region (22, 40) . An early analysis pointing to the existence of a specific L-amino acid binding site showed that L-Phe and the phenylalkylamine R467 exerted significant positive interactions on receptor activation (62) . Furthermore, mutations in the region of the key lobe I VFT domain residue S170 appeared to selectively impair amino acid responses (63) . The hypothesis that amino acids bind in the CaR's VFT domain has been recently confirmed by chimeric receptor analysis (40) . In this study, replacement of the CaR's Cys-rich, transmembrane domain, and intracellular COOH-terminal domain by the corresponding domains of the rat mGlu-1 receptor, so that only the CaR's VFT domain remained, preserved amino acid sensing. Removal of the CaRs entire VFT domain, however, eliminated amino acid sensing, leaving Ca 2ϩ and phenylalkylamine-sensing intact (40) . Thus L-amino acids bind in a stereoselective site in the CaR's VFT domain demonstrating that its amino acid homology to other family C receptors is indicative of functional as well as structural relationships. A model of the dimeric VFT domains of the CaR with two bound amino acid molecules is presented in Fig. 3 . It is not known whether this form is preferred or whether, instead, the dimeric CaR might more readily adopt a closed-open configuration as described for the mGlu-1 receptor (36, 51).
Amino Acid-Induced Signaling Mechanisms
The CaR couples to various G-protein linked intracellular signaling pathways. Key elements in these pathways include PI-PLC, intracellular Ca 2ϩ mobilization, PKC, PLA2, PLD, PI-3-kinase, and several mitogen-activated protein kinases, including ERK 1/2, p38, and JNK, all of which are activated by elevated Ca 2ϩ , Gd 3ϩ , or Mg 2ϩ concentrations, and adenylyl cyclase, which in parathyroid cells is inhibited by CaR activators (for reviews, see Refs. 7, 57). If L-amino acids were simply allosteric enhancers acting to sensitize the CaR to its cationic activators, it might be supposed that they would act with equally facility on all CaR-linked pathways. Recent analysis suggests, however, that, on a background of a suprathreshold Ca 2ϩ o , amino acids selectively activate a discrete intracellular signaling pathway in HEK293 cells that induces intracellular Ca 2ϩ mobilization and has only a limited impact on PI-PLC (46).
In our initial experiments, which were conducted on large populations of fura 2-loaded cells, we observed continuous amino acid-induced elevations in cytoplasmic free Ca 2ϩ concentration. Digital imaging analysis of fura 2-loaded single CaR-expressing HEK293 cells, however, indicates that, on a background of a submaximal Ca 2ϩ o , CaR-active amino acids such as L-Phe induced characteristic low-frequency oscillations (1-2 min Ϫ1 ) in cytoplasmic free Ca 2ϩ concentration (60) . Elevations in Ca 2ϩ o above the chosen baseline level, 1.8 mM, also induced oscillations in cytoplasmic free Ca 2ϩ concentration, but these tended to be higher in frequency (3-5 min Ϫ1 ) and took the form of sinusoidal waves rather than spikes. These differences in intracellular Ca 2ϩ response appear to arise from differences in the signaling pathways that are initiated by -induced oscillatory responses appear to require repetitive PKC-dependent phosphorylation and dephosphorylation of T888 in the CaR's COOH-terminal tail (61). The mutant T888A, which was previously shown to eliminate the CaR's extracellular Ca 2ϩ -dependent sensitivity to PKC (3, 28), for example, exhibited continuous broad responses to elevated Ca 2ϩ o , very similar to the impact of PKC inhibitors on the wild-type CaR (61) . Amino acid-induced oscillations in intracellular Ca 2ϩ , on the other hand, were preserved in T888A. These data indicate that the CaR exhibits differential signaling in response to amino acids and extracellular Ca 2ϩ , and a more recent analysis has provided insights into elements of the amino acid-induced intracellular pathway upstream of Ca 2ϩ oscillations in CaR-expressing HEK293 cells (46) . These appear to include the heterotrimeric G-proteins, G 12 or G 13 , the CaR's distal COOH terminus, possibly corresponding to the filamin-binding domain, the small G-protein Rho, and the actin cytoskeleton. Because inhibition of none of these components disrupted extracellular Ca 2ϩ -induced signaling, the results appear to justify the conclusion that the CaR adopts specific conformations in response to either elevated Ca 
Modes of Operation of the CaR
We originally envisaged that the CaR operates in several different modes dependent on specific changes in the nutrient composition of the compartment in which it is expressed (16). In one mode, it behaves as a Ca 2ϩ receptor under conditions in which the Ca 2ϩ o changes either generally, requiring responses from the parathyroid, thyroid C-cells, and renal tubular cells, or locally, e.g., in response to receptor-mediated Ca 2ϩ efflux (26) . In a second mode, it behaves as an amino acid receptor under conditions in which the Ca 2ϩ o is stable and above threshold. Because the threshold Ca 2ϩ concentration lies between 0.5 and 1.0 mM, i.e., below the normal Ca 2ϩ o of 1.1-1.3 mM, this mode of operation would appear to be important in all compartments exposed to significant variations in amino acid concentration, particularly in the distribution of the portal vein at the time of protein digestion and amino acid absorption but also systemically because amino acid concentrations undergo dynamic changes in systemic blood under these circumstances (for review, see Ref. 14) . A third mode is also apparent in which Ca 2ϩ and amino acids are both elevated, e.g., in the portal circulation after a protein-and calcium-rich meal. Although the basic concepts described above still seem reasonable, the finding that amino acids and supraphysiological concentrations of Ca 2ϩ (Ͼ1.5 mM) activate distinct signaling pathways in CaR-expressing HEK293 cells indicates that a refinement is required. Thus the receptor not only responds in different modes to either amino acids or elevated Ca 2ϩ concentration but, in doing so, can select specific biological responses dependent on the cell signaling apparatus available. A prominent feature of the amino acid-induced responses in CaR-expressing HEK293 cells (16, 60) and normal human parathyroid cells (15) is intracellular Ca 2ϩ mobilization, known to be a potent stimulus for hormone as well as fluid and electrolyte secretion from various cell types in the GI tract.
CaR Expression in the GI Tract
Because the CaR responds to amino acids with a selectivity for aromatic and aliphatic amino acids similar to that identified for various GI processes, it seems reasonable to ask whether the CaR mediates amino acid sensing by some or many of the specialized cells and tissues of the GI tract and to consider the physiological roles that such sensing mechanisms might play.
To answer these questions, it is first necessary to consider where the CaR is expressed. Analysis of CaR expression by immunohistochemistry indicates that it is widely expressed in epithelial cells and neurons of the stomach, small intestine, and large intestine. In the stomach, for example, the CaR is expressed in acid-secreting gastric parietal cells and pepsinogensecreting chief cells of the gastric glands (13) as well as surface mucus-secreting cells (48) (for review, see Ref. 23 ). Expression in these sites suggests roles in the control of gastric acid, pepsinogen, and mucus secretion, and there is now good evidence that activation of the CaR does indeed support gastric acid secretion in either the absence or presence of the potent secretagogue histamine (21) . In the antrum of the stomach, the CaR is also expressed on gastrin-secreting G cells (9, 45) , and CaR activators stimulate intracellular Ca 2ϩ mobilization via the activation of PI-PLC (9) and, at least in part, via the activation of dihydropyridine-sensitive voltage-operated Ca 2ϩ channels (45) . CaR expression on both the apical and basolateral membranes of G cells (45) (Fig. 4) indicates that they are responsive to changes in the nutrient composition of both the luminal contents and blood.
In the small intestine, the CaR is expressed at high levels on the basal membranes of the small intestinal villous and crypt epithelial cells (12) and in epithelial cells of Brunner's submucosal glands (Fig. 5) , which secrete a bicarbonate-rich fluid into the lumen of the duodenum (12) . In the colon, however, it is expressed on both the apical and basolateral membranes of the epithelial cells of the crypts (12) . Expression in these small and large intestinal sites suggests roles in the control of water and electrolyte transport; in the small intestine, the effects of CaR activation are largely unknown. In the colon, however, it seems clear that CaR activation promotes fluid absorption and interferes with secretion, at least in part, by antagonizing cAMP-dependent pathways from either the apical or basolateral membranes (12) (for review, see Ref. 23) .
The pancreas and hepatobiliary system empty via a merged ductal system into the duodenum and are critical for normal digestion and absorption of nutrients via, in the case of the pancreas, the secretion of zymogens (protease precursors such as trypsinogen, chymotrypsinogen, and procarboxypeptidases) and an isotonic bicarbonate-rich juice and, in the case of the hepatobiliary system, bile salts in the form of mixed micelles in a neutral or alkaline isotonic fluid. Expression of the CaR on the basolateral membranes of pancreatic acinar cells and apical membranes of pancreatic duct cells (8) suggests roles in the control of pancreatic enzyme and fluid secretion, although this has not yet been established, and expression on hepatocytes has been linked to Ca 2ϩ -stimulated bile flow (11) . Interestingly, the CaR does not appear to be expressed on other types of liver cells including Kupffer, endothelial, and stellate cells or on cells of the bile ducts (11) .
Although the pattern of expression in enteroendocrine cells has not been fully determined, it is clear that the CaR is expressed by gastrin-secreting G cells of the gastric antrum (9, 45) and that CCK-secreting small intestinal I cells require evaluation. Consistent with this latter idea, the CaR-activating amino acid L-Phe has been shown to stimulate CCK secretion (32, 37) and CCK-dependent pancreatic fluid secretion (39) . The CaR is also expressed by neurons of the submucosal and myenteric plexuses throughout the stomach and intestine (12) implying roles in the control of fluid and electrolyte secretion and motility.
Regulation of Digestion and Absorption: What Are the Roles of Amino Acid-Activated CaRs?
The following discussion focuses on cells of the GI tract that 1) regulate digestion and absorption and/or contribute to the control of appetite and satiety; 2) express the CaR; and/or 3) are known to respond to aromatic amino acids, such as L-Phe and L-Trp.
Gastric phase of digestion. Upon the entry of food into the stomach, activated pepsin preferentially cleaves ingested proteins on the COOH-terminal sides of aromatic amino acids, including L-Phe, L-Trp, and L-Tyr, especially in the presence of an aromatic or other hydrophobic amino acid on the COOH side of the cleavage site (for review, see Ref. 29) . Thus, as a result of pepsin action, some short hydrophobic peptides and free aromatic amino acids are released and, before exiting the stomach for absorption in the small intestine, free aromatic amino acids together with calcium ions wash over the apical surfaces of gastrin-secreting G cells in the pyloric antrum. The physiological response as demonstrated by the oral ingestion of calcium and/or peptide hydrolysates (peptones) (5) is the release of the peptide hormone gastrin followed by the activation of gastric acid secretion to promote digestion and the further release of peptides and amino acids. Both extracellular Ca 2ϩ (9, 45) and aromatic amino acids, including L-Phe and L-Trp (19, 50, 52) , are recognized signals for gastrin release. Furthermore, CaRs expressed in the apical membranes of G cells are a likely target, because they mediate pronounced elevations in cytoplasmic free Ca 2ϩ concentration, a potent stimulus for gastrin release (9, 45) . Gastrin released into the capillary network of the stomach acts primarily on enterochromaffin-like cells in the submucosa of the gastric glands to release histamine and thus stimulate gastric acid secretion via the activation of H2 receptors on parietal cells.
It seems likely, however, that intestinally absorbed amino acids can also stimulate gastric acid release and that this process too is under CaR control, in gastric parietal cells. The demonstration that the CaR is expressed by parietal cells may explain previous observations that gastric acid secretion is activated not only by luminal amino acids, but also by intravenous infusions of amino acids including L-Phe and L-Trp (27, 33, 38) . Consistent with this idea, elevated Ca 2ϩ and other multivalent cation activators of the CaR mobilize intracellular Ca 2ϩ in gastric parietal cells and stimulate acid secretion in a manner that is sensitive to proton pump inhibitors (21) . Elevations in intracellular Ca 2ϩ concentration can act either alone or in concert with histamine-induced elevations in cAMP to activate the insertion of proton pumps into the apical membrane from intracellular tubulovesicles (Fig. 6 ). In addition, it has been shown recently that the CaR-active amino acids, L-Phe and L-Trp, stimulate acid secretion from isolated gastric glands in a manner that is highly dependent on variations in the Ca 2ϩ o between 1.0 and 2.0 mM, behavior that is typical of the CaR (10) . Although the system L-amino acid transporter may also contribute to amino acid-induced activation of gastric acid secretion (30) , the specific inhibitor 2-amino-2-norbornanecarboxylic acid did not block these effects of L-Phe or L-Trp (10) .
Intestinal phase of digestion. In the upper small intestine, the major pancreatic protease, chymotrypsin, like pepsin, selectively cleaves proteins and peptides on the COOH side of aromatic and hydrophobic amino acid residues. This suggests that aromatic amino acids may also be preferentially released in the intestinal phase of digestion to promote, at least initially, continuing gastric acid and pepsin release after their absorption and delivery to CaRs on parietal cells in the gastric fundus while, separately, initiating key events that promote the intestinal phase of digestion and absorption. Consistent with this idea, an analysis of human jejunal contents for both free and peptide amino acids before and 3 h after the ingestion of a protein-rich meal indicated that aromatic and some other nonpolar amino acids were preferentially released compared with aliphatic, polar, and acidic amino acids (2) . For example, under these conditions, between 40 and 60% of the total L-Phe and L-Tyr but only ϳ12-15% of the total L-Ala, L-Ser, L-Thr, and L-Glu in the jejunal contents were present in their free amino acid forms. It thus seems plausible that the early entry and/or release of free aromatic amino acids into the intestinal luminal fluid provides signals for the secretion of small intestinal hormones, notably CCK, whose secretion is known to be activated by L-Phe both in vivo and in vitro (4, 32, 37). CCK release, like gastrin release, is dependent on elevations in intracellular Ca 2ϩ concentration that are blocked by an inhibitor of voltage-operated Ca 2ϩ channels, diltiazem (37) . Although it is tempting to hypothesize that the CaR mediates this effect of amino acids on CCK secretion, it remains to be shown that intestinal I cells express the CaR and, if so, whether it is expressed primarily on the apical membrane where it could potentially respond to intraluminal amino acids or the basolateral membrane where it would require absorbed amino acids.
The release of peptides (1) and free amino acids into the small intestinal lumen is followed shortly thereafter by their cellular absorption and, in the case of short peptides, after the action of intracellular peptidases, the release of free amino acids into the portal blood (2) . CaRs expressed on hepatocytes, which are bathed by portal blood, are known to be coupled to the control of bile flow (11). It is not yet certain whether Ca 2ϩ , amino acids, or other putative physiological activators of the CaR regulate bile flow at the time of nutrient digestion; however, the concept that bile flow is coupled to the ingestion of nutrients is clearly attractive. Furthermore, CaRs expressed on pancreatic acinar cells may also participate in the control of pancreatic fluid and enzyme secretion (8) . Whether activation of the CaR by Ca 2ϩ , amino acids, or other gut-derived activators such as spermine has effects on other secretory glands, e.g., on bicarbonate secretion from Brunner's submucosal glands or pancreatic ducts, is currently uncertain.
Coincident with these effects, amino acids acting on CaRs on enteric nerves have the potential to modify enteric motor responses, which are primarily coordinated by the myenteric plexus, and/or secretory motor responses, which are coordinated by the submucous plexus, and/or communicate changes in intestinal nutrient levels to feeding and satiety centers via autonomic sensory nerves. As noted above, expression of the CaR has been detected throughout the intestinal plexuses (12) . In one scenario, it seems possible that amino acid-activated CaRs on neurons of the myenteric plexus act to promote small intestinal digestion and absorption, e.g., by slowing anterograde peristalsis and by promoting static, segmenting movements. In addition, delivery of L-Phe into the small intestinal lumen is recognized as a potent satiety stimulus that may Ezrin is a PKA phosphorylation target protein of the cytoskeleton. Myosin light chain kinase (MLCK) has been implicated in the pathway from receptors coupled to Ca 2ϩ mobilization. Activated gastric acid secretion appears to arise from receptor-mediated fusion of intracellular tubulovesicles, containing the H ϩ /K ϩ ATPase (proton pump) and parchorin (Cl Ϫ channel), with the plasma membrane (59) . Both amino acids (AAs) and Ca 2ϩ ions are depicted as activators of the CaR. A putative alternative mechanism for the action of amino acids on acid secretion via the system L-transporter is also shown (30) . ECL, enterochromaffin-like cells.
operate either by the release of CCK (4) or via the activation of neuronal circuits linked to central satiety centers.
As described above, the potential scope of the effects of amino acid-activated CaRs is wide on the basis of the extensive distribution of the CaR in the GI tract and the sensitivity of many GI processes to aromatic amino acids. A limited set of the effects proposed above is presented in diagrammatic form in Fig. 7 .
Is There a Role for the CaR in Intestinal Calcium Absorption?
Although the ability of the CaR to sense both amino acids and Ca 2ϩ ions is now well established, and this review has demonstrated how the CaR may act in the GI tract as a key switch for the control of various steps in digestion and absorption, it might be wondered whether dual regulation of the CaR also has an impact on intestinal calcium absorption. Recent analysis of this question indicates that the CaR may indeed be involved. Thus, in humans with absorptive hypercalciuria, an increased sensitivity of gastric acid secretion to the oral ingestion of calcium and protein hydrolysates has been detected (5). Elevated gastric acid production could promote calcium absorption by facilitating the release of calcium ions from insoluble precipitates.
Alternatively, CaR activation might promote the activity of intestinal epithelial Ca 2ϩ channels. The recent molecular cloning of the Ca 2ϩ channels responsible for epithelial calcium transport in the kidney and intestine, now known as TRPV5 and TRPV6, respectively, should facilitate analysis of this question (25, 42) . Consistent with a possible role for the CaR in the regulation of intestinal calcium absorption, it is expressed locally by small intestinal epithelial cells (12) . In addition, variations in dietary calcium intake regulate the expression of epithelial Ca 2ϩ transport channels independent of changes in 1,25 dihydroxyvitamin D levels (for review, see Ref. 55 ) and, interestingly, in the 1␣-OHase knockout mouse, high dietary calcium rescued the phenotype, at least in part, by promoting expression of TRPV6 in the duodenum (54) . Although the significance of this result for the normal physiological control of intestinal calcium absorption is not yet certain, it does point to a possible regulatory role for the CaR.
Summary and Conclusions
There has been an explosion of interest in the CaR since it was first cloned (7). The realization that it has multiple ligand binding sites, is activated by multiple physiologically important biochemical species, and couples to ligand-selective signaling pathways has rather added to its charm. The story that is now evolving for amino acids in the gut, including effects on digestion, absorption, and satiety, is one fascinating facet of the new biology that is emerging.
